Some major insurance companies are opting not to pay commissions for plans sold on the Affordable Care Act’s marketplaces. Will this decision make enrollment season more difficult for consumers?
KHN’s Julie Appleby joined forces with USA Today to create this chart, which details the various industry players and how they contribute to a prescription drug’s cost.
High-intensity focused ultrasound, often not covered by insurance, leads to discussions about which patients benefit in the real world.
The number of prescriptions for Medicare beneficiaries is on the rise, too.
The flu vaccine is available for longer windows of time. Experts say to weigh convenience and science in deciding when to roll up your sleeve.
Based on an analysis of insurance company payments, emergency room visits and lab tests were responsible for much of the overall spending.
As news that Mylan will make available a generic version of its own brand-name product, KHN answers key questions about how this development could affect consumers.
Research shows exercise-based cardiac rehab programs help heart patients heal faster and live longer. But fewer than a third take part. Time and cost are the main barriers, doctors and patients say.
Insurance claims for medical services related to opioid dependence diagnoses rose more than 3,000 percent between 2007 and 2014, an analysis finds.
Federal spending has soared for drugs that are handmade in local pharmacies, and federal investigators are raising concerns about fraud or overbilling.
The case alleges that insured consumers were overcharged because of a contract agreement.
After once being considered a preferred vaccine option for children, a CDC advisory panel recommended the spray should not be used in the upcoming flu season.
The U.S Preventive Services Task Force recently expanded the list of approved colorectal cancer screening tests. Here’s a primer on these various tests and how they might be covered now and in the future by health insurance.
Amid growing concern about rising drug costs, the practices of prescription benefit management firms are drawing a new level of attention.
The Medicare Payment Advisory Commission outlined a package of changes to Medicare’s drug program that could save billions of dollars.
A proposal to change the way Medicare pays for some drugs has set off intense reaction and lobbying — all tied to a common theme: How far should the government go in setting prices for prescription drugs?
The federal agency says the wellness programs can get health details about workers and their spouses as long as the financial rewards or penalties do not exceed 30 percent of the cost for an individual in the company’s group health plan.
Gina McCarthy met with Kaiser Health News to answer a range of questions, including how the agency is involved in efforts to combat Zika and the ongoing water crisis in Flint, Michigan.
The proposal that Medicare made this month to better control prescription drug costs involves testing strategies used with some success in the private sector.
The Department of Health and Human Services issues new rules designed to simplify health coverage consumers buy through Healthcare.gov.